Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate CancerPhilip W. Kantoff, Wayne R. Godfrey, Thomas Schuetz et al.|Journal of Clinical Oncology|2010Cited by 973
Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor CellsBenjamin Boyerinas, Jeffrey Schlom, Caroline Jochéms et al.|Cancer Immunology Research|2015Cited by 456
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid TumorsJulius Strauss, James L. Gulley, Christopher R. Heery et al.|Clinical Cancer Research|2018Cited by 415
Current Landscape of Immunotherapy in Breast CancerSylvia Adams, Elizabeth A. Mittendorf, Margaret E. Gatti‐Mays et al.|JAMA Oncology|2019Cited by 409
Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate CancerJames L. Gulley, William L. Dahut, Anne Bastian et al.|Clinical Cancer Research|2005Cited by 371